During the past decade, Hospital General La Mancha Centro conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 2 clinical trials were completed, i.e. on average, 15.4% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital General La Mancha Centro" #1 sponsor was "Castilla-La Mancha Health Service" with 2 trials, followed by "Fundación GECP" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Dr. Negrin University Hospital" with 1 trials sponsored and "Faes Farma, S.A." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital General La Mancha Centro" #1 collaborator was "Asociación Científica Pulmón y Ventilación Mecánica" with 1 trials as a collaborator, "Complejo Hospitalario La Mancha Centro" with 1 trials as a collaborator, "Consorcio Centro de Investigación Biomédica en Red (CIBER)" with 1 trials as a collaborator, "Dynamic Science S.L." with 1 trials as a collaborator and "Effice Servicios Para la Investigacion S.L." with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Hospital General La Mancha Centro" are "Lung Cancer" (2 trials), "Type 1 Diabetes" (2 trials), "Acute Respiratory Insufficiency" (1 trials), "Allergic Conjunctivitis" (1 trials) and "Breast Cancer, Male" (1 trials). Many other conditions were trialed in "Hospital General La Mancha Centro" in a lesser frequency.

Most popular intervention types in "Hospital General La Mancha Centro" are "Drug" (5 trials), "Device" (3 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bilastine" (1 trials), "COVID-19 vaccine" (1 trials), "Chemotherapy- scheme" (1 trials), "Colonic resection" (1 trials) and "Double Dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital General La Mancha Centro" are 13 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital General La Mancha Centro". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Hospital General La Mancha Centro, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital General La Mancha Centro, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".